valine has been researched along with Diabetes Mellitus, Type 1 in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 9 (52.94) | 29.6817 |
| 2010's | 5 (29.41) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Aukland, SM; Elgen, IB; Fehn, JR; Fevang, SKE; Irgens, H; Njølstad, PR; Sirnes, E; Sulen, Å; Svalastoga, P; Valen, E | 1 |
| Boncelj, M; Eržen, B; Janež, A; Janić, M; Kanc, K; Lunder, M; Šabović, M; Savić, V | 1 |
| Amini, M; Gheissari, A; Javanmard, SH; Khalili, N; Shirzadi, R | 1 |
| Chang, KC; Ha, YM; Kang, YJ; Kim, HJ; Park, EJ; Park, SW | 1 |
| Crikelair, N; Lastra, G; Levy, DG; Rocha, R; Seifu, Y; Sowers, JR | 1 |
| Fukamachi, S; Hino, R; Kimura, T; Kobayashi, M; Nakamura, M; Tokura, Y | 1 |
| Hattersley, AT; Jones, AG | 1 |
| Chan, P; Cheng, JT; Liu, IM; Tzeng, TF; Wong, KL; Yang, TL | 1 |
| Andersen, S; Jacobsen, P; Jensen, BR; Parving, HH | 1 |
| Bohren, KM; Gabbay, KH; Nadkarni, V; Owerbach, D; Song, JH | 1 |
| Hausberg, M; Hohage, H; Kosch, M | 1 |
| Brismar, K; Dahlquist, G; Forsblom, C; Groop, PH; Marklund, SL; Möllsten, A; Parkkonen, M; Svensson, M; Wessman, M | 1 |
| Dalton, RN; Dunger, DB; Marcovecchio, ML; Widmer, B | 1 |
| Chauffert, M; Chevenne, D; Cisse, A; Michel, S; Parfait, B; Trivin, F | 1 |
| Lawrie, WC; Maclean, MA; McGowan, PE; Reglinski, J; Spickett, CM; Walker, JJ; Wilson, R; Wisdom, S | 1 |
| Cheng, ZJ; Luft, FC; Mervaala, EM; Muller, D; Nurminen, K; Park, JK; Ruskoaho, H; Tikkanen, I; Vapaatalo, H; Vaskonen, T | 1 |
| Shimoni, Y | 1 |
2 trial(s) available for valine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Initial combination therapy compared with monotherapy in diabetic hypertensive patients.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Glucose; Blood Pressure; C-Reactive Protein; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Severity of Illness Index; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2008 |
Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy.
Topics: Adult; Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Double-Blind Method; Drug Synergism; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Tetrazoles; Valine; Valsartan | 2003 |
15 other study(ies) available for valine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Intellectual Disability in K
Topics: Adolescent; Amino Acid Substitution; Case-Control Studies; Child; Child, Preschool; Codon, Nonsense; Cohort Studies; Diabetes Mellitus, Type 1; Female; Genetic Association Studies; Genotype; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intellectual Disability; Male; Methionine; Mutation, Missense; Norway; Potassium Channels, Inwardly Rectifying; Sulfonylurea Receptors; Valine | 2020 |
Improvement of arterial wall characteristics by the low-dose fluvastatin and valsartan combination in type 1 diabetes mellitus patients.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Anticholesteremic Agents; Blood Pressure; Carotid Arteries; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Indoles; Male; Middle Aged; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2013 |
Lowering effect of valsartan on fetuin-A in type 1 diabetes mellitus.
Topics: Adult; Albuminuria; alpha-2-HS-Glycoprotein; Angiotensin II Type 1 Receptor Blockers; Cholesterol, LDL; Creatine; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Female; Glycated Hemoglobin; Humans; Male; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan; Young Adult | 2013 |
Valsartan independent of AT₁ receptor inhibits tissue factor, TLR-2 and -4 expression by regulation of Egr-1 through activation of AMPK in diabetic conditions.
Topics: AMP-Activated Protein Kinases; Angiotensin II Type 1 Receptor Blockers; Animals; Blotting, Western; Cells, Cultured; Chromatin Immunoprecipitation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Early Growth Response Protein 1; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Glucose Tolerance Test; Humans; Male; Mice; Mice, Inbred C57BL; Monocytes; Receptor, Angiotensin, Type 1; RNA, Small Interfering; Tetrazoles; Thromboplastin; Toll-Like Receptor 2; Toll-Like Receptor 4; Valine; Valsartan | 2014 |
Palmar pseudolymphoma associated with herpes simplex infection.
Topics: Acyclovir; Antiviral Agents; Diabetes Mellitus, Type 1; Female; Hand Dermatoses; Herpes Simplex; Humans; Immunohistochemistry; Middle Aged; Pseudolymphoma; Valacyclovir; Valine | 2010 |
Reevaluation of a case of type 1 diabetes mellitus diagnosed before 6 months of age.
Topics: Administration, Oral; Adolescent; Amino Acid Substitution; Developmental Disabilities; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Epilepsy; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Infant; Methionine; Mutation; Potassium Channels, Inwardly Rectifying; Syndrome; Valine | 2010 |
Antihyperglycemic action of angiotensin II receptor antagonist, valsartan, in streptozotocin-induced diabetic rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Glucose; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Gene Expression; Glucose Tolerance Test; Glucose Transporter Type 4; Hyperglycemia; Liver; Male; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Nicorandil; Nifedipine; Phosphoenolpyruvate Carboxykinase (GTP); Rats; Rats, Wistar; RNA, Messenger; Saralasin; Tetrazoles; Valine; Valsartan | 2003 |
A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus.
Topics: Amino Acid Sequence; Amino Acid Substitution; Cell Line; Diabetes Mellitus, Type 1; Genes, Reporter; Genetic Predisposition to Disease; Heat-Shock Proteins; Humans; Lysine; Methionine; Molecular Sequence Data; NF-kappa B; Oxidative Stress; Polymorphism, Genetic; Recombinant Proteins; Sequence Alignment; Small Ubiquitin-Related Modifier Proteins; Tissue Distribution; Transcription Factors; Valine | 2004 |
[Hypertension and diabetic nephropathy, a dangerous duo].
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diuretics; Drug Therapy, Combination; Enalapril; Glomerular Filtration Rate; Humans; Hypertension; Male; Metabolic Syndrome; Ramipril; Tetrazoles; Valine; Valsartan | 2005 |
A functional polymorphism in the manganese superoxide dismutase gene and diabetic nephropathy.
Topics: Adult; Age of Onset; Alanine; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Finland; Homozygote; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Smoking; Superoxide Dismutase; Sweden; Valine | 2007 |
Effect of acute variations of insulin and glucose on plasma concentrations of asymmetric dimethylarginine in young people with Type 1 diabetes.
Topics: Adolescent; Arginine; Biomarkers; Blood Glucose; Creatinine; Diabetes Mellitus, Type 1; Drug Administration Schedule; Female; Glucose Clamp Technique; Humans; Insulin; Male; Phenylalanine; Valine; Young Adult | 2008 |
HLA-DQ beta 1 typing and non-Asp57 alleles in the aborigine population of Senegal.
Topics: Adolescent; Adult; Alleles; Aspartic Acid; Black People; Child; Diabetes Mellitus, Type 1; Female; Gene Frequency; Genetic Carrier Screening; Genetic Predisposition to Disease; Genotype; Histocompatibility Testing; HLA-DQ Antigens; HLA-DQ beta-Chains; Homozygote; Humans; Male; Native Hawaiian or Other Pacific Islander; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Racial Groups; Reference Values; Risk Factors; Senegal; Valine | 1995 |
1H NMR as a non-invasive probe of amniotic fluid in insulin dependent diabetes mellitus.
Topics: Acetates; Alanine; Amniotic Fluid; Citric Acid; Diabetes Mellitus, Type 1; Female; Glucose; Humans; Lactic Acid; Magnetic Resonance Spectroscopy; Pregnancy; Pregnancy in Diabetics; Pregnancy Trimester, Third; Valine | 1999 |
Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats.
Topics: Acetylcholine; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Diabetes Mellitus, Type 1; Endothelium, Vascular; Heart Rate; Hypertension; In Vitro Techniques; Mesenteric Arteries; Neprilysin; Nitroprusside; Norepinephrine; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sodium, Dietary; Tetrazoles; Valine; Valsartan | 2001 |
Inhibition of the formation or action of angiotensin II reverses attenuated K+ currents in type 1 and type 2 diabetes.
Topics: Action Potentials; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Carrier Proteins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Electric Conductivity; Isoquinolines; Mutation; Potassium Channels; Quinapril; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor, Angiotensin, Type 2; Receptors, Cell Surface; Receptors, Leptin; Saralasin; Tetrahydroisoquinolines; Tetrazoles; Valine; Valsartan | 2001 |